Clinical trial for safe, affordable stem cell based medicine

(Source: The Med Guru, 18 February 2011)
Stempeutics Research, a Bangalore-based company, has got the permission from the Drug Controller General of India (DCGI) to carry out its 2nd phase of clinical trials in patients with type 2 diabetes [Also called non-insulin dependent diabetes; a condition in which the pancreas produces so little insulin that the body cannot use the blood glucose as energy; can often be controlled through meal plans and physical activity plans, and diabetes pills or insulin.] , liver cirrhosis, chronic obstructive pulmonary [pertains to lungs and respiratory system] disease, and osteoarthritis. Read more